Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated

J R Hobbs1, M Monteil, D R McCluskey

  • 1Department of Immunology, Charing Cross and Westminster Medical School, Westminster Hospital, London, United Kingdom.

Insights

Bone marrow transplants can successfully treat chronic granulomatous disease (CGD) in children. Complete displacement of abnormal marrow with donor cells ensures a normal childhood, highlighting the importance of early intervention.

Area of Science:

  • Immunology
  • Pediatric Hematology
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by a lack of functional cytochrome B-245 in phagocytes.
  • CGD leads to recurrent severe infections and significant morbidity, often with fatal outcomes in childhood.

Observation:

  • A boy with CGD, whose sibling died from the disease, presented with non-functional phagocytes resistant to interferon gamma stimulation.
  • He received an elective unrelated donor bone marrow transplant at 8 months of age.

Findings:

  • The transplant resulted in 100% replacement of the patient's CGD granulocytes with normal donor cells.
  • The patient has experienced a normal childhood for three years post-transplant, indicating successful engraftment and immune reconstitution.

Implications:

  • This case underscores the efficacy of bone marrow transplantation for CGD, emphasizing complete marrow ablation with busulphan for stable engraftment.
  • Early elective transplantation before irreversible organ damage is crucial for optimal outcomes.
  • Further research is needed to establish criteria for early identification of high-risk CGD patients requiring intensive management.